Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 33.8% in First Half of 2022

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 381.1 million yuan in the first half of 2022, down 33.8% year-on-year.

Meanwhile, the company posted 881.3 million yuan in revenue, down 24.8% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 409.2 million yuan in total liabilities, with a liability-to-asset ratio of 4.2%.